Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Molecular and Cellular Endocrinology|May 25, 2021
Role of sex hormones in modulating breast and ovarian cancer associated painMelissa C McHann, Henry L Blanton, Josée GuindonBrain Research Bulletin|September 16, 2021
Sex and dose-dependent antinociceptive effects of the JNK (c-Jun N-terminal kinase) inhibitor SU 3327 are mediated by CB2 receptors in female, and CB1/CB2 receptors in male mice in an inflammatory pain modelHenry L Blanton, Agata Pietrzak, Melissa C McHann, et al.Drugs|May 26, 2019
Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic PainHenry L Blanton, Jennifer Brelsfoard, Nathan DeTurk, et al.Pharmacology, Biochemistry, and Behavior|January 14, 2021
Sex differences and the endocannabinoid system in painHenry L Blanton, Robert C Barnes, Melissa C McHann, et al.Frontiers in Pharmacology|March 4, 2022
Chronic Administration of Cannabinoid Receptor 2 Agonist (JWH-133) Increases Ectopic Ovarian Tumor Growth and Endocannabinoids (Anandamide and 2-Arachidonoyl Glycerol) Levels in Immunocompromised SCID Female MiceHenry L Blanton, Melissa C McHann, Haley De Selle, et al.Neuropharmacology|November 24, 2019
c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific mannerAngela N Henderson-Redmond, Caitlin M Nealon, Brian J Davis, et al.Pageof 1